These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27638828)

  • 1. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
    Péchery A; Fauconnet S; Bittard H; Lascombe I
    Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
    Elie-Caille C; Lascombe I; Péchery A; Bittard H; Fauconnet S
    Mol Cell Biochem; 2020 Aug; 471(1-2):113-127. PubMed ID: 32519230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206.
    Gu L; Shi Y; Xu W; Ji Y
    Oncol Res; 2019 Aug; 27(8):923-933. PubMed ID: 30982495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes.
    Kim WJ; Lee W; Jung Y; Jang HJ; Kim YK; Kim SN
    Biochem Biophys Res Commun; 2019 Mar; 510(4):621-628. PubMed ID: 30739791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40.
    Li J; Xu S; Liu Y; Yan Z; Zhang F; Lv Q; Tong N
    Lipids; 2019 Oct; 54(10):603-616. PubMed ID: 31364177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis.
    Ji Y; Li H; Wang F; Gu L
    Front Pharmacol; 2018; 9():648. PubMed ID: 30002625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization.
    Tobita Y; Arima T; Nakano Y; Uchiyama M; Shimizu A; Takahashi H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes.
    Zarei M; Barroso E; Palomer X; Escolà-Gil JC; Cedó L; Wahli W; Vázquez-Carrera M
    Clin Investig Arterioscler; 2019; 31(3):111-118. PubMed ID: 30987865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
    Chistyakov DV; Astakhova AA; Goriainov SV; Sergeeva MG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
    Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
    Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor β/δ abrogation.
    Hirao-Suzuki M; Takeda S; Koga T; Takiguchi M; Toda A
    J Toxicol Sci; 2020; 45(4):227-236. PubMed ID: 32238697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle.
    Phua WWT; Tan WR; Yip YS; Hew ID; Wee JWK; Cheng HS; Leow MKS; Wahli W; Tan NS
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.
    Sarre C; Contreras-Lopez R; Nernpermpisooth N; Barrere C; Bahraoui S; Terraza C; Tejedor G; Vincent A; Luz-Crawford P; Kongpol K; Kumphune S; Piot C; Nargeot J; Jorgensen C; Djouad F; Barrere-Lemaire S
    Stem Cell Res Ther; 2022 Apr; 13(1):167. PubMed ID: 35461240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
    Barbaud A; Lascombe I; Péchery A; Arslan S; Kleinclauss F; Fauconnet S
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells.
    Smith RW; Coleman JD; Thompson JT; Vanden Heuvel JP
    Biochem Biophys Rep; 2016 Dec; 8():395-402. PubMed ID: 28955982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples.
    Sibille B; Mothe-Satney I; Le Menn G; Lepouse D; Le Garf S; Baudoin E; Murdaca J; Moratal C; Lamghari N; Chinetti G; Neels JG; Rousseau AS
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction.
    Rasul A; Bao R; Malhi M; Zhao B; Tsuji I; Li J; Li X
    Molecules; 2013 Jan; 18(2):1418-33. PubMed ID: 23348995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.
    Liu YC; Lin KH; Hsieh JH; Chung JG; Tan ZL; Hsu FT; Chiang CH
    In Vivo; 2019; 33(6):1865-1877. PubMed ID: 31662514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARδ agonist enhances colitis-associated colorectal cancer.
    Zhou D; Jin J; Liu Q; Shi J; Hou Y
    Eur J Pharmacol; 2019 Jan; 842():248-254. PubMed ID: 30391747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.